Press release
Neuroendocrine Tumor Market Size, Share, Growth, Research and Forecast 2019-2025
The global neuroendocrine tumor market is projected to grow at a CAGR of around 10% during the forecast period. The market is studied on the basis of treatment type, indication, and end-user. Amongst the indication, the global neuroendocrine tumor market is segmented into the lungs, pancreas, gastrointestinal, and others. The gastrointestinal segment holds a significant share in the market. The segmental growth is attributed to the increased incidences of gastrointestinal diseases such as colon cancer, tumor in the intestine, and many others. The rising prevalence of several gastrointestinal diseases has been recorded globally. As per WHO, gastric cancer has been the fifth most common cancer globally in which malignant (cancer) cells form in the lining of the stomach.A full report of Global Neuroendocrine Tumor Market is available at: https://www.omrglobal.com/industry-reports/neuroendocrine-tumor-market
Smoking and ulcer are some major factors leading to gastric cancer. Additionally, other factors including age factor, diet, and stomach disease such as gastrointestinal reflux disease (GERD) can increase the risk of developing gastric cancer. Symptoms of gastric cancer include indigestion and stomach discomfort or pain. It has been noted that about 6 out of 10 people with the age of 65 years or older are expected to be diagnosed with gastric cancer. Additionally, the average risk of a person developing stomach cancer in their lifetime is about 1 in 111.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/neuroendocrine-tumor-market
In the US, more than 26,240 incidences of gastric cancer were recorded in 2018 which is about 15% of all new cancer cases, according to the National Cancer Institute. The situations are more severe in Asian countries such as Japan and China. For instance, Japan has around 132,800 cases of stomach cancer in 2017. Similar trends were observed in China as around 498,000 gastric cancer deaths were recorded. Such an increasing number of cases increase the demand for better treatment options, which in turn, drive the growth of the global neuroendocrine tumor market.
Current Market Trends Covered in the Market Report:
o Increased investments by the government and private organizations towards the introduction and development of various treatment methods and drugs is positively affecting the neuroendocrine tumor industry growth during the forecast period
o Somatostatin Analogs (SSA)segment will account for a significant share in the neuroendocrine tumor market
o Novel drug development and several product pipelines are the key strategies of the key players
o North America to hold a considerable share in the market across the globe
Global Neuroendocrine Tumor Market - Segmentation
By Treatment Type
o Somatostatin Analogs (SSA)
o Targeted Therapy
o Chemotherapy
o Others
By Indication
o Lungs
o Pancreas
o Gastrointestinal
o Others
By End-User
o Hospital& Clinics
o Others
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/neuroendocrine-tumor-market
Global Neuroendocrine Tumor Market - Segmentation by Region
North America
o United States
o Canada
Europe
o Germany
o United Kingdom
o France
o Spain
o Italy
o Rest of Europe
Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific
Rest of the World
o Middle East & Africa
o Latin America
Company Profiles
o AVEO Pharmaceuticals Inc.
o Boehringer Ingelheim International GmbH
o Bristol-Myers Squibb Co.
o Dauntless Pharmaceuticals, Inc.
o Eli Lilly & Co.
o Exelixis, Inc.
o F. Hoffmann-La Roche Ltd.
o Hutchison MediTechLtd.
o Ipsen Group
o Mateon Therapeutics, Inc.
o Novartis International AG
o Pfizer Inc.
o Progenics Pharmaceuticals, Inc.
o Tarveda Therapeutics, Inc.
o Teva Pharmaceutical Industries, Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroendocrine Tumor Market Size, Share, Growth, Research and Forecast 2019-2025 here
News-ID: 2037340 • Views: …
More Releases from Orion Market Research

Document Outsourcing Services Market Size Unlocking New Opportunities for Succes …
In 2023, the Global Document Outsourcing Services Market was estimated at USD 9.81 billion, and by 2033, it is anticipated to reach approximately USD 24-25 billion, reflecting an approximate CAGR of around 12.2% from 2024 to 2033.
Document Outsourcing Services Market Overview
The Document Outsourcing Services Market is witnessing steady growth as organizations increasingly delegate document-intensive processes such as printing, scanning, storage, and data management to specialized service providers. Rising digital transformation…

Distribution Automation Market Analysis Current Landscape and Future Outlook
The global Distribution Automation Market was valued at USD 14.5 billion in 2023 and is projected to reach USD 31.7 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 8.14% by 2033.
Distribution Automation Market Overview
Distribution Automation (DA) is transforming the power sector by integrating intelligent electronic devices, advanced communication networks, and real-time control software to enhance grid reliability and operational efficiency. Growing investment in smart grid modernization,…

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…
More Releases for Neuroendocrine
Neuroendocrine Carcinoma Market Massive Growth opportunity Ahead
Introduction
Neuroendocrine carcinoma (NEC) is a rare and aggressive form of cancer that arises from neuroendocrine cells, which are found throughout the body and are responsible for producing hormones. These tumors can occur in various organs, including the lungs, pancreas, liver, and gastrointestinal tract. Due to its often vague and non-specific symptoms, neuroendocrine carcinoma is frequently diagnosed at an advanced stage, making it challenging to treat effectively.
In recent years, however, there…
Rising Neuroendocrine Tumors Fuel Treatment Market Growth Driving Market Acceler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuroendocrine Tumor Treatment Market Size By 2025?
The industry for treating neuroendocrine tumors has witnessed substantial growth in the previous years. The market size is projected to escalate from $2.17 billion in 2024 to $2.4 billion in 2025, with a compound annual growth rate (CAGR)…
Emerging Trends Influencing The Growth Of The Neuroendocrine Tumor Treatment Mar …
The Neuroendocrine Tumor Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Neuroendocrine Tumor Treatment Market Size Expected to Be by 2034?
The market for neuroendocrine tumor treatment has seen a significant expansion in recent years. Projected to grow from a value…
Prominent Neuroendocrine Tumor Treatment Market Trend for 2025: Clinical Trials …
How Are the key drivers contributing to the expansion of the neuroendocrine tumor treatment market?
The neuroendocrine tumor treatment market is forecasted to expand due to the increasing incidence of neuroendocrine tumors. Neuroendocrine tumors, or NETs, are rare growths that begin in neuroendocrine cells, and their treatment is vital to managing the symptoms, controlling the tumor's growth, and applying radiation therapy to destroy the cancerous cells. The American Society of Clinical…
Neuroendocrine Tumor Treatment Market – Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Neuroendocrine Tumor Treatment Market is projected to grow from USD 1.8 billion in 2021 to USD 2.1 billion by 2026 at a CAGR value of 5.7% between 2021 to 2026. High prevalence of neuropsychiatric malignancy, awareness regarding early cancer diagnosis, and an increasing number of government initiatives, the neuroendocrine tumor therapy market is expected to rise…
Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Gro …
The market report titled ‘Global Neuroendocrine Cancer Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.
Neuroendocrine Cancer Market Segmentation Analysis
Total Neuroendocrine Cancer Studies: 2499
By Drug Type
Everolimus
Sunitinib Malate
Lanreotide
Octreotide
Others
Sunitinib (Sutent) and Everolimus (Afinitor) are two major targeted drugs that are being used for the treatment of…